iktos vs molecule.one

iktos logo

iktos

Artificial intelligence for new drug design

85 employees · est. 2016 · Paris, France

VS
molecule.one logo

molecule.one

Autoresearch for chemistry

37 employees · est. 2019 · San Francisco, United States

iktos is the older company (2016 vs 2019); iktos is the larger of the two.

Side-by-Side Comparison

iktos molecule.one
Founded
2016 older 2019
Headquarters
Paris, France San Francisco, United States
Employees
85 larger 37
Industry
AI, Biotechnology, Health Care AI, Pharmaceutical
Funding Stage
Series A Seed
Total Funding
$18.90M $4.99M
Funding Rounds
7 3
Services
Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics Robotic High-Throughput Synthesis, AI-Powered Chemical Reaction Mapping, On-Demand Molecule Delivery, Licensing of Synthesis Platform
Target Customers
Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams Pharmaceutical Companies, Biotechnology Firms, Chemical Researchers, CROs (Contract Research Organizations)
Taxonomy
Drug DesignMedicinal ChemistryGenerative AIChemoinformaticsRobotics AutomationSaaS Software +8 Artificial_intelligenceChemical_synthesisMolecule_designPreclinical_pipelineInformation_technologyBioinformatics +7
Website
iktos.ai molecule.one
iktos logo

About iktos

Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's...

molecule.one logo

About molecule.one

molecule.one is an innovative startup operating at the intersection of AI and Pharmaceutical industries. Founded in 2019 and headquartered in the United States, the company is leveraging artificial intelligence and data-driven approaches to design creative and accurate chemical syntheses. Aligning...

Also comparing in this category

Comparing more than these two?

Get iktos, molecule.one and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does iktos compare?

A PDF of iktos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

iktos was founded in 2016, based in Paris, France, with 85 employees. Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," enc. molecule.one was founded in 2019, based in San Francisco, United States, with 37 employees. molecule.one is an innovative startup operating at the intersection of AI and Pharmaceutical industries. Founded in 2019 and headquartered in the United States, the company is leveraging artificial in.
iktos has raised $18.90M and molecule.one $4.99M. Latest stage: iktos Series A, molecule.one Seed.
Both work in AI and Pharmaceutical.

Compare iktos with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at iktos on 20 Sep 2026, and molecule.one on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes